Literature DB >> 23943283

Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Seok-Byung Lim1, Chang Sik Yu, Chan Wook Kim, Yong Sik Yoon, Seong Ho Park, Tae Won Kim, Jong Hoon Kim, Jin Cheon Kim.   

Abstract

PURPOSE: To identify the indication and prognostic significance of lateral lymph node (LLN) excision in locally advanced rectal cancer patients underwent preoperative chemoradiotherapy.
METHODS: Included were 67 consecutive patients with suspicious LLN metastasis who underwent chemoradiotherapy and surgery including selective LLN excision (82 excisions). The excisions were grouped according to the presence of LLN metastasis and compared in terms of the clinicopathological findings and oncological results. The correlation between the largest short-axis diameter of LLN measured by imaging and metastasis rates was explored.
RESULTS: LLN metastases were identified in 32 excisions (40.0 %). The calculated short-axis LLN diameter predicting metastasis was 11.7 mm (before chemoradiotherapy) and 11.4 mm (before surgery). LLN metastasis was observed more frequently in the low rectum (p = 0.031) and associated with higher CEA levels (p = 0.048). The 3-year overall survival rates for patients with and without LLN metastasis were 60.3 % and 90.3 % (p = 0.048), while the 3-year disease-free survival rates were 31.4 % and 70.5 % (p = 0.009). The hazard ratio of LLN metastasis for recurrence was 2.938 (95 % CI = 1.258-6.863).
CONCLUSIONS: LLN metastasis in rectal cancer patients underwent chemoradiotherapy was a distinct poor prognostic factor. Selective LLN excision based on imaging studies may have a role for such patients.

Entities:  

Mesh:

Year:  2013        PMID: 23943283     DOI: 10.1007/s00384-013-1761-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

Review 1.  Lateral node dissection and total mesorectal excision for rectal cancer.

Authors:  T Takahashi; M Ueno; K Azekura; H Ohta
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

2.  Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  Tae Hyun Kim; Seung-Yong Jeong; Dong Hyun Choi; Dae Yong Kim; Kyung Hae Jung; Sung Ho Moon; Hee Jin Chang; Seok-Byung Lim; Hyo Seong Choi; Jae-Gahb Park
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

Review 4.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

5.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

6.  Treatment of locally recurrent rectal cancer.

Authors:  J Garcia-Aguilar; J W Cromwell; C Marra; S H Lee; R D Madoff; D A Rothenberger
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

7.  Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Hirokazu Nagawa; Masatoshi Oya; Masashi Ueno; Hiroya Kuroyanagi; Yoshiya Fujimoto; Takashi Akiyoshi; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  World J Gastrointest Surg       Date:  2010-04-27

8.  Prognostic determinants of patients with lateral nodal involvement by rectal cancer.

Authors:  H Ueno; H Mochizuki; Y Hashiguchi; K Hase
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

9.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

10.  Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.

Authors:  Jin C Kim; Keiichi Takahashi; Chang S Yu; Hee C Kim; Tae W Kim; Min H Ryu; Jong H Kim; Takeo Mori
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

View more
  16 in total

1.  S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection.

Authors:  Hye Jin Kim; Gyu-Seog Choi; Jun Seok Park; Soo Yeun Park; Seung Hyun Cho; An Na Seo; Ghuil Suk Yoon
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach.

Authors:  Kinuko Nagayoshi; Takashi Ueki; Tatsuya Manabe; Taiki Moriyama; Kosuke Yanai; Yoshinao Oda; Masao Tanaka
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

Review 3.  Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.

Authors:  Y Atef; T W Koedam; S E van Oostendorp; H J Bonjer; A R Wijsmuller; J B Tuynman
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

4.  Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach.

Authors:  Hye Jin Kim; Gyu-Seog Choi; Jun Seok Park; Soo Yeun Park; Hee Jae Lee; In Taek Woo; In Kyu Park
Journal:  Surg Endosc       Date:  2017-11-09       Impact factor: 4.584

Review 5.  Is There Any Reason to Still Consider Lateral Lymph Node Dissection in Rectal Cancer? Rationale and Technique.

Authors:  Miranda Kusters; Keisuke Uehara; Cornelis J H van de Velde; Yoshihiro Moriya
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

6.  Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Masakazu Yamamoto; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

7.  Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer: multicentre retrospective cohort study.

Authors:  Han-Ki Lim; Minjung Kim; Ji Won Park; Seung-Bum Ryoo; Kyu Joo Park; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang; Dong Woon Lee; Sung Chan Park; Jae Hwan Oh; Seung-Yong Jeong
Journal:  BJS Open       Date:  2022-05-02

8.  Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.

Authors:  Yusuke Yamaoka; Yusuke Kinugasa; Akio Shiomi; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa; Masakatsu Numata; Akinobu Furutani
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

9.  Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer.

Authors:  Yasuhiro Inoue; Susumu Saigusa; Junichiro Hiro; Yuji Toiyama; Toshimitsu Araki; Koji Tanaka; Yaushiko Mohri; Masato Kusunoki
Journal:  Mol Clin Oncol       Date:  2016-04-08

10.  Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.

Authors:  Jian-Hao Geng; Yang-Zi Zhang; Yong-Heng Li; Shuai Li; Lin Wang; Zhi-Long Wang; Xiang-Gao Zhu; Zhao-De Bu; Zi-Yu Li; Xiang-Qian Su; Yong Cai; Ai-Wen Wu; Wei-Hu Wang
Journal:  Ann Transl Med       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.